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Introduction
Alcohol consumption is a major public health problem,
and the cause of about 4% of the global burden of disease.
This proportion is similar to that of tobacco and hyper-
tension, and has risen to about 7% and 12% in western
and eastern Europe, respectively.1 Rates of alcohol
consumption in the general population have been known
to be associated with those of liver cirrhosis mortality for
almost half a century,2 and cirrhosis mortality rates are an
important indicator of alcohol harms.3 They have been
inﬂuential in the WHO reviews of options for alcohol
policies over three decades.4–6
Total recorded alcohol consumption in Britain doubled
between 1960 and 2002. This was the result of several
factors: a reduction in the real price of alcohol, an increase
in availability of alcohol, and heavy promotion by the
alcohol industry.3 The Chief Medical Ofﬁcer for England
has previously drawn attention to the cirrhosis mortality
rate for England, which roughly trebled between 1970 and
1998, while the European Union rate reduced by about
30%.7 In this study, we examine trends in liver cirrhosis
mortality rates in Scotland and in England and Wales up
to 2002, and place them in the context of corresponding
trends in other western European countries over the past
50 years. 
Methods
Mortality rates were calculated from data in the WHO
Mortality Database downloaded from the Geneva website
in August, 2005. At the time of writing this constitutes the
most detailed consolidated European data on cirrhosis
mortality. It contains counts of deaths by cause, single
year of death, 5-year age-group, and sex for all countries
reporting mortality to WHO from 1950 to 2002, together
with the corresponding population denominators. These
data were those lodged with the WHO by the
corresponding national statistics ofﬁces. 
Mortality rates were calculated for all ages and speciﬁc
age-groups (15–44 years and 45–64 years) for cirrhosis of
the liver. Rates were directly age-standardised to the
European standard population. Over the period
1950–2002, several different revisions of the International
Classiﬁcation of Diseases (ICD) were used. The codes
used to deﬁne cirrhosis of the liver were: A105 (full code
581) in ICD7; A102 (full code 571) in ICD8; B348 (full
code 571) in ICD9; and K70, K73, K74 in ICD10. 
Age-standardised mortality rates for Scotland and for
England and Wales combined were calculated for
1950–2002, both as annual rates and as 5-year aggregates.
These rates were compared with those for 12 other
western European countries and with the mean rate for
these countries. The countries and years included in this
comparison group were dictated by the need to have a
complete series for each country included for as long a
period of time as possible. 11 countries had yearly
mortality data available for every year from 1955 to 2001:
Austria, Finland, France, Germany (data for East and
West Germany before uniﬁcation were combined),
Ireland, Italy, Netherlands, Norway, Portugal, Spain, and
Sweden, but Denmark only had data for 1955–2000. In
2000, the mid-year population of these 12 countries
comprised 73% of the population of all western European
countries (excluding the UK). The mean mortality rate for
this comparative group of other European countries was
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Summary
Background Rates of mortality due to cirrhosis of the liver are an important indicator of population levels of alcohol
harm. Total recorded alcohol consumption in Britain doubled between 1960 and 2002, giving rise to a need to examine
and assess cirrhosis mortality trends. 
Methods Mortality rates were calculated for all ages and for speciﬁc age-groups (15–44 years and 45–64 years) for
cirrhosis of the liver. Rates were directly age-standardised to the European standard population and compared with rates
from 12 western European countries for the period 1955–2001.
Findings Cirrhosis mortality rates increased steeply in Britain during the 1990s. Between the periods 1987–1991, and
1997–2001, cirrhosis mortality in men in Scotland more than doubled (104% increase) and in England and Wales rose
by over two-thirds (69%). Mortality in women increased by almost half (46% in Scotland and 44% in England and
Wales). These relative increases are the steepest in western Europe, and contrast with the declines apparent in most
other countries examined, particularly those of southern Europe. Cirrhosis mortality rates in Scotland are now one of
the highest in western Europe, in 2002 being 45·2 per 100 000 in men and 19·9 in women.
Interpretation Current alcohol policies in Britain should be assessed by the extent to which they can successfully halt the
adverse trends in liver cirrhosis mortality. The situation in Scotland warrants particular attention. 
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calculated as the arithmetic mean of age-standardised
rates for every country. This calculation was done in
preference to calculating a mean weighted by population
size, since we wished to elucidate Britain’s position
relative to the distribution of rates by country rather than
relative to some arbitrary aggregate European population.
Average yearly changes in mortality rates in Scotland and
in England and Wales over the most recent decade
(1997–2001 compared with 1987–91) were estimated from
a linear regression of rates against individual year as a
continuous variable. Data management and analyses were
done in STATA version 8.0.
Results
Since the early 1950s, there has been a substantial
increase in liver cirrhosis mortality rates in Scotland and
in England and Wales for both men and women (ﬁgure).
The steady increase that took place until the end of the
1970s accelerated in the 1980s, and again from 1990 to
1994 onwards. Between 1950–54 and 2000–02, rates in
men increased by a factor of ﬁve in England and Wales,
and a factor of six in Scotland. In women there were
corresponding four-fold increases in rates. The pattern of
increase was similar in both the 15–44 years age-group
and the 45–64 years age-group, although the absolute rates
in the older age-group were much higher. 
By sharp contrast, mortality rates for both men and
women, and for both age-groups, for the mean of other
European countries rose steeply from 1955, reaching a
peak in the early 1970s. Subsequently, reductions in mean
mortality rates of 25–30% have been seen in men in both
age-groups and in older women, with little consistent
change in rates over time in women aged 15–44 years.
Across both age-groups and sexes, the mortality rates in
Scotland are now about double that of the European
comparison group, with the rates in England and Wales
rapidly approaching or greater than the European mean. 
Trends in the mean of other European countries
obscure striking country-speciﬁc and regional variations.
As can be seen in table 1 there has been a steady long-term
decline in mortality rates in France, accompanied by a
more recent substantial reduction in the predominantly
wine-drinking countries of southern Europe (Italy, Spain,
and Portugal) in both men and women. In northern
Europe, reductions in rates are apparent in Germany,
Austria, and Sweden for both sexes, and in Norwegian
men. Increases in mortality rates over both recent and
longer term time periods are seen in Finland,
Netherlands, and Ireland in both sexes and in Danish
men, and increasingly in Danish women. These various
changes in rates have resulted in the position of England
and Wales relative to other countries moving steadily
upwards from having the lowest cirrhosis mortality rates
in 1957–62. The relative position of Scottish women and
men has also deteriorated. In the latest period for which
comparisons were possible (1997–2001), they have the
second and third highest rates respectively.
1957–1961 1987–1991 1997–2001
Men Women Men Women Men Women
Austria 43·4 13·5 56·6 18·1 43·5 16·7
Denmark 11·7 15·6 28·0 12·9 34·2* 15·6*
England and Wales 3·4 2·2 8·3 5·4 14·1 7·7
Finland 9·9 5·5 23·8 8·1 28·7 9·9
France 48·4 19·9 31·9 14·1 28·1 10·8
Germany 25·2 11·1 35·8 14·5 33·6 13·9
Ireland 5·4 3·9 7·8 5·3 11·1 6·5
Italy 29·6 10·2 37·4 16·2 26·5 12·2
Netherlands 7·8 4·7 9·4 5·3 9·7 5·9
Norway 7·7 6·6 13·1 6·1 12·1 6·7
Portugal 43·3 19·0 52·4 16·9 34·7 11·1
Scotland 8·2 6·1 16·9 11·1 34·4 16·1
Spain 28·9 14·2 34·8 11·0 25·1 8·2
Sweden 9·2 4·7 13·7 6·2 13·5 5·6
Rates directly age-standardised to the European standard population. *Rates are 1997–2000 only.
Table 1: Standardised mortality rates for liver cirrhosis at all ages per 100 000 per year 
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Figure: Time trends in age-standardised mortality rates for liver cirrhosis per 100 000 by age-group, sex, and
country between 1950 and 2002
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The extent of changes (1997–2001 relative to 1987–91) in
mortality rates in speciﬁc age-groups and at all ages are
shown in table 2 in the form of comparative mortality
ratios (100 representing no change). The countries of
southern Europe and France have had the largest
proportional reductions in death rates due to liver
cirrhosis in men and women. By contrast, several
northern European countries (including Scotland,
England, and Wales) have seen increases. 
The rate of increase in mortality rates over the recent
decade is highest in Scottish men in all age-groups, and in
Scottish women aged 45 years or older. For women aged
15–44 years, the rate of increase for those in England and
Wales alone exceeds that in Scotland. Within the 45–64
years age-group, only Irish and Finnish women, and
above 65 years only Irish men, have higher rates of
increase in cirrhosis mortality than those in England and
Wales and in Scotland. At all ages, British men and
women have, by some margin, the largest proportional
increases in mortality during this time.
Table 3 provides data on the absolute rather than the
relative increase in rates over the decade in these same
age-groups and for all ages in Scotland, and in England
and Wales. The steepest increase in mortality rates in both
England and Wales and in Scotland are seen in the
45–64 years age-group for both sexes.
Discussion
Over the past quarter of a century, the reduction in
cirrhosis mortality rates in western Europe has largely
been driven by the decline in overall alcohol
consumption in the mainly wine-drinking countries of
southern Europe. Increases in cirrhosis mortality rates
have been seen across the beer-drinking and spirit-
drinking cultures of northern Europe. The British trends
thus represent an exaggerated example of these wider
northern European trends, resembling most closely the
trends in Ireland. In Britain, however, the increases in
mortality rates are steeper, are apparent for both men and
women, exist across all age-groups, and are accelerating.
Although Britain used to have some of the lowest
cirrhosis mortality rates in Europe, this advantage
has been rapidly eroded. Scotland in particular now has
some of the highest rates in western Europe. Although
absolute rates in England and Wales remain relatively
low, in the most recent years they have risen steeply and
are now on a par with or have exceeded the western
European average. 
There have been several changes in the ICD used to
categorise cause of death. There has been particular
concern about changes in the deﬁnition of alcohol-related
deaths as a consequence of the shift from ICD9 to ICD10
in England and Wales.8 However, ICD10 was only
introduced in England and Wales in 2001 and in Scotland
in 2000, ICD9 having previously been in place throughout
the UK from 1979. Thus the steep rise in cirrhosis
mortality in Britain has been evident throughout this time
and cannot be an artifact of change in ICD revisions. With
respect to the other European countries mentioned here,
the change to ICD9 occurred in 1979 or later (with the
15–44 years 45–64 years 65 years All ages
Men Women Men Women Men Women Men Women
Scotland 227 170 218 163 177 141 204 146
England and Wales 224 185 184 146 123 108 169 144
Ireland 135 160 158 163 148 105 143 123
Denmark* 110 111 119 130 105 85 122 121
Finland 99 105 120 147 122 94 121 122
Netherlands 108 95 97 112 79 84 103 112
Sweden 84 50 77 77 93 95 98 91
Germany 97 81 90 92 80 82 94 96
Norway 66 108 97 97 75 83 93 110
France 91 66 78 76 77 84 88 77
Austria 69 64 72 87 80 86 77 92
Spain 69 57 59 51 64 69 72 74
Italy 76 57 53 57 62 78 71 76
Portugal 80 83 65 59 66 62 66 66
Countries sorted in descending order of size of comparative mortality ratios for men all ages. Comparative mortality ratios based on ratio of mortality rates age-standardised to the
European standard population. *Comparative mortality ratios for Denmark based on ratio of rates for period 1997–2000 to 1987–1991.
Table 2: Comparative mortality ratios for liver cirrhosis, 1997–2001 relative to 1987–1991, by age-group
England and Wales Scotland
Men Women Men Women
Rate in 2002 per 100 000 per year
15–44 6·5 3·4 15·8 6·5
45–64 28·9 14·9 72·6 32·8
65 26·7 6·8 57·5 24·9
All ages 17·5 9·4 45·2 19·9
Change in rate per 100 000 (95% CI) per decade for 1993–2002
15–44 3·5 (2·3–4·8) 1·6 (0·9 –2·3) 12·1 (8·9–15·3) 1·4 (2·3–5·1)
45–64 17·1 (15·5–18·7) 6·8 (6·0–7·7) 47·2 (39·8–54·6) 17·7 (14·9–20·5)
65 7·8 (4·8–10·9) 3·6 (2·5–4·8) 32·0 (20·7–43·2) 8·2 (3·1–13·2)
All ages 10·0 (6·6–13·4) 4·4 (3·2–5·7) 29·7 (24·6–34·8) 7·3 (3·4–11·1)
Rates directly age-standardised to the European Standard population. Change in rate per decade estimated from a linear
regression of rates against individual year as a continuous variable. 
Table 3: Liver cirrhosis age-standardised mortality rates per 100 000 in England and Wales and in
Scotland 
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exception of Denmark, which has never used this
revision), whereas the change to ICD10 took place
between 1994 and 1999.
This acceleration of the longer-term trend in liver
cirrhosis mortality rates across Britain is extremely
worrying, and needs to be urgently addressed. This
concern is especially true for Scotland, where rates have
exceeded those in England and Wales since the early
1930s, with the differential widening consistently since
the early 1950s,9 especially so since the early 1990s in those
in middle age. The most obvious cause of the increase in
rates across Britain since the early 1970s is increasing
overall alcohol consumption. Per capita alcohol
consumption has more than doubled in the UK over the
past 40 years. Although beer consumption has been
stable, increased consumption of wine and spirits in
particular have contributed in a disproportionate way to
this trend.3 Thus the relative effect of changing overall
consumption is difﬁcult to separate from that of changes
in the types of alcohol being drunk.
Time series analyses of cirrhosis mortality in
14 European countries from 1950 to 1995 have established
that change in overall rates of drinking is accompanied by
change in rates of cirrhosis mortality.10 The strongest
associations between changing rates of consumption and
cirrhosis mortality are seen in those northern European
countries in which drinking of spirits predominates.10
After earlier analyses,11 Roizen and colleagues12 in the
USA, and Kerr and co-workers13 in ﬁve predominantly beer-
drinking English-speaking countries, identiﬁed spirits
consumption to be largely responsible for the associations
between alcohol and mortality rates from cirrhosis of the
liver. Some interpretations of these data have regarded these
speciﬁc associations of spirits as being due to unknown
confounders in the absence of a precisely deﬁned
biological mechanism.14 Kerr and colleagues, however, do
not discount the possibility that it is the toxic properties of
the spirits themselves that are the causal agents.15 It is
plausible that greater consumption of more potent forms
of alcohol (spirits and wine) enhances the effect on
cirrhosis mortality of changing average consumption. 
Another possible explanation is increased heavy
drinking.16 This suggestion is not supported, however, by
the available self-reported male consumption data, in
which the proportion of men drinking above various risk
thresholds has increased only modestly since the late
1980s in Britain.17 However, substantial increases in
consumption by women, particularly younger women,
have been reported over the same period.17 Somewhat
strangely, the self-reported data reveal no substantial
differences between Scotland on the one hand, and
England and Wales on the other. However, binge
drinking, which is not well captured in available survey
data, has previously been proposed to be more common in
Scotland .18 It is possible that there have been undetected
increases in heavy drinking, or increased consumption in
those who are already heavy drinkers. The absence of
high-quality alcohol consumption data, particularly on a
regional and national basis, is a profound handicap to
further study. 
Although attention has been focused on alcohol, it is
important to note that Britain has experienced an
epidemic of hepatitis C in current and former injecting
drug users. This increase might account for some of the
increase in cirrhosis mortality.19 However, there are
several respects in which the patterns of hepatitis C
infection do not ﬁt with our ﬁndings about cirrhosis
mortality. First, prevalent hepatitis C cases are in general
in younger people. For example, 86% of the 8000 cases
diagnosed by Scottish laboratories from 1991 to 1998 were
aged between 15 and 44 years, and only 9% were aged
45–69 years.20 By contrast, the proportional increases in
cirrhosis mortality over the same period were similar in
both age-groups. Second, southern Europe has also
experienced an increase in hepatitis C for similar reasons,
but rates of cirrhosis there have been declining. Italy, for
example, has about double the prevalence of injecting
drug use, and also roughly double the prevalence of
hepatitis C among injecting drug users as Britain.21
Unfortunately, further rigorous assessment of the
contribution of hepatitis C to these trends and differences
is hampered by the absence of comparable international
trend data for incidence and prevalence.22
Several other causal factors have been implicated in liver
cirrhosis. These include nutritional factors such as
obesity, which seems to be associated with increased risk
of liver cirrhosis independent of alcohol consumption.23
However, differences in obesity are unlikely to provide an
explanation for the international differences we noted,
since there is no correlation between obesity and liver
cirrhosis rates for the countries we have assessed.24 For
example, Austria and Denmark have notably high rates of
cirrhosis mortality for both men and women, but in 2000
had a prevalence of obesity of under 10%—half that seen in
Britain. Moreover, despite the big differences between
Scotland on the one hand, and England and Wales on the
other as regards to cirrhosis mortality, in 1998 the
prevalence of obesity in Scotland in those aged 16–74 years
was only slightly higher than in England: 20% versus 17%
in men, and 22% versus 21% in women.25 With respect to
the temporal trends in cirrhosis, although rates of obesity
have increased substantially in Britain over the past few
decades, they have also increased in many other European
countries, including some of those which now show steep
downward trends in cirrhosis mortality such as Spain.26
Finally, the role of socioeconomic disadvantage per se needs
to be considered. Cirrhosis in Britain has historically been
contrasted with that in the US as being a disease of the
afﬂuent rather than the poor.11 However, socioeconomic
disadvantage in itself is unlikely to provide an explanation
for the trends and differences we have seen. 
What explains what is happening in Scotland? Between
1890 and 1910, the cirrhosis mortality in Scotland was
about half that in England and Wales.9 The situation
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nowadays is the reverse. Indeed, overall life-expectancy and
mortality in Scotland is not improving as much as in most
other western European countries, with smoking in
particular identiﬁed as a major contributor.27 Better data
and further research on drinking patterns and on other
potential determinants of cirrhosis mortality, such as
hepatitis C and obesity, are needed to understand fully the
substantial and widening differences in cirrhosis mortality
between Scotland and England and Wales. 
Although the contribution of obesity and hepatitis C to
national mortality rates due to liver cirrhosis has yet to be
clearly shown and quantiﬁed, as we have argued above,
there is very strong evidence that alcohol is a major driver
of population cirrhosis mortality rates in high income
countries. In this context, the British Government has
decided to eschew speciﬁc control of the overall rate of
drinking as an instrument of public policy in the ﬁrst ever
strategy for alcohol harm reduction in England,28 despite
the rapidly increasing cirrhosis mortality rates. The recent
comprehensive deregulation of local alcohol controls will
further increase alcohol availability, with the likely
consequence of increasing consumption.29 An early
assessment of increased availability in Scotland in the
1970s identiﬁed no harmful effect on the basis of broad
similarity in trend data from England and Wales.30 To us,
this ﬁnding seems both premature and too narrowly
focused.
Almost 40 years ago, a long-term cross-national
comparative study concluded that “The methods used in
the United Kingdom which have succeeded in reducing
mortality from cirrhosis of the liver are, ﬁrst, progressive
increases in taxation of alcoholic beverages in order to
decrease their availability to increasing proportions of the
population and, second, restriction of the hours of sale of
alcoholic beverages.”11 We seem to be currently unlearning
the lessons available to us from history, with what are likely
to be predictable consequences. If limiting overall
consumption is not an acceptable goal for alcohol policy,
perhaps cirrhosis mortality rates are an appropriate key
indicator of the extent to which alcohol harms are really
reduced. 
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